Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Galantamine on Cognition
NCT01100775Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- May 2010
- Primary completion
- Aug 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of galantamine in schizotypal personality disorder (STPD), schizophrenia, sponsored by University of Maryland, Baltimore. Started May 2010; status: completed.
02
Drugs
galantamine
03
Conditions
schizotypal personality disorder (STPD)schizophrenia
Beyond the preview
Go deeper on NCT01100775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100775.